ArticleEClinicalMedicine2021

Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.

Vinicius Fontanesi Blum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.